NR3C1 and breast carcinoma: Additionally, experimental models found that the expression of the glucocorticoid receptor was associated with improved breast cancer prognosis, particularly for ER + tumours, and that activation of the glucocorticoid receptor may reduce estrogen-induced cell proliferation in ER + breast cancer [18].